In the contemporary era, the germ theory of infections remains a cornerstone of medical science, guiding research, diagnostics, and therapeutic strategies. Advances in technology, such as DNA sequencing and molecular biology techniques, have allowed scientists to delve deeper into the complexities of microbial pathogens and host interactions. Genomic studies have enabled the identification of virulence factors, mechanisms of antimicrobial resistance, and the exploration of microbial communities within the human body. This detailed understanding of the molecular underpinnings of infections has facilitated the development of precision medicine approaches, allowing for personalized treatments based on the specific characteristics of the infecting microorganism. Moreover, the germ theory has influenced public health measures, emphasizing the importance of vaccination, sanitation, and infection control practices. Vaccination campaigns have led to the eradication or significant reduction of many infectious diseases, showcasing the practical impact of the germ theory on global health. However, challenges such as emerging infectious diseases, antimicrobial resistance, and the ongoing COVID-19 pandemic underscore the continued relevance of the germ theory. Ongoing research aims to address these challenges by developing new vaccines, antimicrobial agents, and innovative strategies grounded in the principles of the germ theory of infections. In this way, the germ theory remains a dynamic and foundational concept in the ongoing battle against infectious diseases.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain